AURINIA PHARMACEUTICALS INC's ticker is and the CUSIP is 05156V902. A total of 4 filers reported holding AURINIA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,083,134 | -43.1% | 654,200 | -29.1% | 0.02% | -41.4% |
| Q2 2023 | $8,936,576 | +11.9% | 923,200 | +26.7% | 0.03% | 0.0% |
| Q1 2023 | $7,984,360 | +183.0% | 728,500 | +11.5% | 0.03% | +314.3% |
| Q4 2022 | $2,821,824 | -39.2% | 653,200 | +5.8% | 0.01% | -22.2% |
| Q3 2022 | $4,644,000 | +22.4% | 617,600 | +63.6% | 0.01% | +50.0% |
| Q2 2022 | $3,795,000 | -49.7% | 377,600 | -38.1% | 0.01% | -14.3% |
| Q1 2022 | $7,548,000 | -72.1% | 609,700 | -48.4% | 0.01% | -68.2% |
| Q4 2021 | $27,032,000 | +92.8% | 1,182,000 | +86.6% | 0.02% | +46.7% |
| Q3 2021 | $14,022,000 | +414.8% | 633,600 | +201.4% | 0.02% | +400.0% |
| Q2 2021 | $2,724,000 | +12.1% | 210,200 | +12.3% | 0.00% | -25.0% |
| Q1 2021 | $2,431,000 | -52.2% | 187,200 | -49.1% | 0.00% | -55.6% |
| Q4 2020 | $5,091,000 | +54.7% | 368,100 | +64.8% | 0.01% | -10.0% |
| Q3 2020 | $3,291,000 | +9.5% | 223,400 | +20.8% | 0.01% | -28.6% |
| Q2 2020 | $3,005,000 | -32.4% | 184,900 | -39.7% | 0.01% | -61.1% |
| Q1 2020 | $4,447,000 | -47.2% | 306,500 | -26.3% | 0.04% | -36.8% |
| Q4 2019 | $8,428,000 | +1157.9% | 416,000 | +231.7% | 0.06% | +1040.0% |
| Q3 2019 | $670,000 | +145.4% | 125,400 | +202.2% | 0.01% | +150.0% |
| Q2 2019 | $273,000 | -12.5% | 41,500 | -13.5% | 0.00% | -33.3% |
| Q1 2019 | $312,000 | +428.8% | 48,000 | +451.7% | 0.00% | +200.0% |
| Q4 2018 | $59,000 | -91.1% | 8,700 | -91.3% | 0.00% | -80.0% |
| Q3 2018 | $661,000 | +15.2% | 99,500 | -2.4% | 0.01% | 0.0% |
| Q2 2018 | $574,000 | +152.9% | 101,900 | +133.2% | 0.01% | +150.0% |
| Q1 2018 | $227,000 | -58.4% | 43,700 | -63.7% | 0.00% | -50.0% |
| Q4 2017 | $546,000 | +1140.9% | 120,500 | +1621.4% | 0.00% | – |
| Q3 2017 | $44,000 | -84.7% | 7,000 | -85.1% | 0.00% | -100.0% |
| Q2 2017 | $288,000 | -85.5% | 47,000 | -82.6% | 0.00% | -87.0% |
| Q1 2017 | $1,986,000 | +845.7% | 270,600 | +171.1% | 0.02% | +1050.0% |
| Q4 2016 | $210,000 | – | 99,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 377,600 | $3,795,000 | 0.01% |
| JANE STREET GROUP, LLC | 668,800 | $6,721,000 | 0.00% |
| SIMPLEX TRADING, LLC | 274,100 | $2,754,000 | 0.00% |
| JPMORGAN CHASE & CO | 87,300 | $877,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |